Viveon Health Acquisition Overview
Viveon Health Acquisition (VHAQ) has a ROE of 9.24%, above the sector sector average of -5.68%.
Get informed when a big investor buys or sells
+ Follow9.24%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Viveon Health Acquisition (VHAQ) currently reports a ROE of 9.24%. That is above the sector sector average of -5.68%. Use the charts on this page to explore Viveon Health Acquisition's ROE history and peer comparisons.
Viveon Health Acquisition's ROE of 9.24% is higher than the its sector sector average of -5.68%. That is roughly 262.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Viveon Health Acquisition's current 9.24% should be judged against industry norms (sector average: -5.68%) and against VHAQ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 9.24%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.68%. From there, open related valuation or income-statement pages for Viveon Health Acquisition, and consider following VHAQ for alerts when major investors trade the stock.
